相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Peripheral administration of tau aggregates triggers intracerebral tauopathy in transgenic mice
Florence Clavaguera et al.
ACTA NEUROPATHOLOGICA (2014)
Novel mutation in MAPT exon 13 (p.N410H) causes corticobasal degeneration
Naomi Kouri et al.
ACTA NEUROPATHOLOGICA (2014)
Association Studies of Sporadic Parkinson's Disease in the Genomic Era
Catherine Labbe et al.
CURRENT GENOMICS (2014)
Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease
Mike A. Nalls et al.
NATURE GENETICS (2014)
Chronic Treatment with Novel Small Molecule Hsp90 Inhibitors Rescues Striatal Dopamine Levels but Not α-Synuclein-Induced Neuronal Cell Loss
Nikolaus R. McFarland et al.
PLOS ONE (2014)
Targeting heat shock proteins to modulate alpha-synuclein toxicity
Daryl Rhys Jones et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2014)
α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson's disease and multiple system atrophy?
Aoife P. Kiely et al.
ACTA NEUROPATHOLOGICA (2013)
LRRK2 phosphorylates novel tau epitopes and promotes tauopathy
Rachel M. Bailey et al.
ACTA NEUROPATHOLOGICA (2013)
Prion-like spreading of pathological α-synuclein in brain
Masami Masuda-Suzukake et al.
BRAIN (2013)
Distinct α-Synuclein Strains Differentially Promote Tau Inclusions in Neurons
Jing L. Guo et al.
CELL (2013)
Genetic Correction of a LRRK2 Mutation in Human iPSCs Links Parkinsonian Neurodegeneration to ERK-Dependent Changes in Gene Expression
Peter Reinhardt et al.
CELL STEM CELL (2013)
α-Synuclein Oligomers Impair Neuronal Microtubule-Kinesin Interplay
Iryna Prots et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Synthetic Tau Fibrils Mediate Transmission of Neurofibrillary Tangles in a Transgenic Mouse Model of Alzheimer's-Like Tauopathy
Michiyo Iba et al.
JOURNAL OF NEUROSCIENCE (2013)
Tau pathology and neurodegeneration
Maria Grazia Spillantini et al.
LANCET NEUROLOGY (2013)
Drosophila melanogaster as a model organism for Alzheimer's disease
Katja Pruessing et al.
MOLECULAR NEURODEGENERATION (2013)
Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease
Silke Appel-Cresswell et al.
MOVEMENT DISORDERS (2013)
Cerebrospinal fluid biomarkers in Parkinson disease
Lucilla Parnetti et al.
NATURE REVIEWS NEUROLOGY (2013)
Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies
David J. Irwin et al.
NATURE REVIEWS NEUROSCIENCE (2013)
Age-appropriate cognition and subtle dopamine-independent motor deficits in aged Tau knockout mice
Meaghan Morris et al.
NEUROBIOLOGY OF AGING (2013)
MAPT H1 haplotype is associated with enhanced α-synuclein deposition in dementia with Lewy bodies
Marti Colom-Cadena et al.
NEUROBIOLOGY OF AGING (2013)
A Powerful Yeast Model to Investigate the Synergistic Interaction of α-Synuclein and Tau in Neurodegeneration
Gianmario Ciaccioli et al.
PLOS ONE (2013)
Age-Dependent Effects of A53T Alpha-Synuclein on Behavior and Dopaminergic Function
Adam W. Oaks et al.
PLOS ONE (2013)
Transmission of multiple system atrophy prions to transgenic mice
Joel C. Watts et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Brain homogenates from human tauopathies induce tau inclusions in mouse brain
Florence Clavaguera et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Evaluation of Potential Infectivity of Alzheimer and Parkinson Disease Proteins in Recipients of Cadaver-Derived Human Growth Hormone
David J. Irwin et al.
JAMA NEUROLOGY (2013)
Looking for novel functions of tau
Jesus Avila et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2012)
The role of MAPT sequence variation in mechanisms of disease susceptibility
Tara M. Caffrey et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2012)
Proteostasis of tau. Tau overexpression results in its secretion via membrane vesicles
Diana Simon et al.
FEBS LETTERS (2012)
Wild type and P301L mutant Tau promote neuro-inflammation and alpha-Synuclein accumulation in lentiviral gene delivery models
Preeti J. Khandelwal et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2012)
Exosomal cell-to-cell transmission of alpha synuclein oligomers
Karin M. Danzer et al.
MOLECULAR NEURODEGENERATION (2012)
Synergistic influence of phosphorylation and metal ions on tau oligomer formation and coaggregation with α-synuclein at the single molecule level
Georg Nuebling et al.
MOLECULAR NEURODEGENERATION (2012)
The neuropathology of genetic Parkinson's disease
Markos Poulopoulos et al.
MOVEMENT DISORDERS (2012)
Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export
Peng Lei et al.
NATURE MEDICINE (2012)
The MAPT locus-a genetic paradigm in disease susceptibility
Richard Wade-Martins
NATURE REVIEWS NEUROLOGY (2012)
LRRK2 Phosphorylates Tubulin-Associated Tau but Not the Free Molecule: LRRK2-Mediated Regulation of the Tau-Tubulin Association and Neurite Outgrowth
Fumitaka Kawakami et al.
PLOS ONE (2012)
Paraquat, but Not Maneb, Induces Synucleinopathy and Tauopathy in Striata of Mice through Inhibition of Proteasomal and Autophagic Pathways
Jonathan Wills et al.
PLOS ONE (2012)
Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
Kelvin C. Luk et al.
SCIENCE (2012)
Independent and Joint Effects of the MAPT and SNCA Genes in Parkinson Disease
Alexis Elbaz et al.
ANNALS OF NEUROLOGY (2011)
Heat Shock Protein 70 Prevents both Tau Aggregation and the Inhibitory Effects of Preexisting Tau Aggregates on Fast Axonal Transport
Kristina R. Patterson et al.
BIOCHEMISTRY (2011)
Region-specific tauopathy and synucleinopathy in brain of the alpha-synuclein overexpressing mouse model of Parkinson's disease
Tiffany Kaul et al.
BMC NEUROSCIENCE (2011)
SNCA, MAPT, and GSK3B in Parkinson disease: a gene-gene interaction study
C. Wider et al.
EUROPEAN JOURNAL OF NEUROLOGY (2011)
Hyperphosphorylated Tau in an α-synuclein-overexpressing transgenic model of Parkinson's disease
Thomas Haggerty et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2011)
Interaction between alpha-synuclein and tau in Parkinson's disease Comment on Wills et al.: Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia. Exp Neurol 2010; 225: 210-218
Kurt A. Jellinger
EXPERIMENTAL NEUROLOGY (2011)
Stimulatory effect of α-synuclein on the tau-phosphorylation by GSK-3ß
Fumitaka Kawakami et al.
FEBS JOURNAL (2011)
Parkinsonian Neurotoxin 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and α-Synuclein Mutations Promote Tau Protein Phosphorylation at Ser262 and Destabilize Microtubule Cytoskeleton in Vitro
Hamid Y. Qureshi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
E46K Human α-Synuclein Transgenic Mice Develop Lewy-like and Tau Pathology Associated with Age-dependent, Detrimental Motor Impairment
Kristel L. Emmer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Induction of Intracellular Tau Aggregation Is Promoted by α-Synuclein Seeds and Provides Novel Insights into the Hyperphosphorylation of Tau
Elisa A. Waxman et al.
JOURNAL OF NEUROSCIENCE (2011)
MAPT H1 HAPLOTYPE IS A RISK FACTOR FOR ESSENTIAL TREMOR AND MULTIPLE SYSTEM ATROPHY
C. Vilarino-Gueell et al.
NEUROLOGY (2011)
Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death
Laura A. Volpicelli-Daley et al.
NEURON (2011)
Do interactions between SNCA, MAPT, and LRRK2 genes contribute to Parkinson's disease susceptibility?
Joanna M. Biernacka et al.
PARKINSONISM & RELATED DISORDERS (2011)
Neuropathological findings of PSP in the elderly without clinical PSP: Possible incidental PSP?
Virgilio Gerald H. Evidente et al.
PARKINSONISM & RELATED DISORDERS (2011)
Tauopathic Changes in the Striatum of A53T α-Synuclein Mutant Mouse Model of Parkinson's Disease
Jonathan Wills et al.
PLOS ONE (2011)
Tau Reduction Does Not Prevent Motor Deficits in Two Mouse Models of Parkinson's Disease
Meaghan Morris et al.
PLOS ONE (2011)
Tau Enhances α-Synuclein Aggregation and Toxicity in Cellular Models of Synucleinopathy
Nahuai Badiola et al.
PLOS ONE (2011)
Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia
Jonathan Wills et al.
EXPERIMENTAL NEUROLOGY (2010)
Synergistic Interactions between Aβ, Tau, and α-Synuclein: Acceleration of Neuropathology and Cognitive Decline
Lani K. Clinton et al.
JOURNAL OF NEUROSCIENCE (2010)
Brain-Permeable Small-Molecule Inhibitors of Hsp90 Prevent α-Synuclein Oligomer Formation and Rescue α-Synuclein-Induced Toxicity
Preeti Putcha et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Parkinson-related parkin reduces α-Synuclein phosphorylation in a gene transfer model
Preeti J. Khandelwal et al.
MOLECULAR NEURODEGENERATION (2010)
Genetic Animal Models of Parkinson's Disease
Ted M. Dawson et al.
NEURON (2010)
Absence of α-synuclein pathology in postencephalitic parkinsonism
Kurt A. Jellinger
ACTA NEUROPATHOLOGICA (2009)
Threonine 53 in α-synuclein is conserved in long-living non-primate animals
Knud Larsen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort
Caroline H. Williams-Gray et al.
BRAIN (2009)
α-Synuclein contributes to GSK-3β-catalyzed Tau phosphorylation in Parkinson's disease models
Tetyana Duka et al.
FASEB JOURNAL (2009)
Propagation of Tau Misfolding from the Outside to the Inside of a Cell
Bess Frost et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Seeding induced by α-synuclein oligomers provides evidence for spreading of α-synuclein pathology
Karin M. Danzer et al.
JOURNAL OF NEUROCHEMISTRY (2009)
What have worm models told us about the mechanisms of neuronal dysfunction in human neurodegenerative diseases?
Dawn Teschendorf et al.
MOLECULAR NEURODEGENERATION (2009)
The role of tau in neurodegeneration
Tania F. Gendron et al.
MOLECULAR NEURODEGENERATION (2009)
Transmission and spreading of tauopathy in transgenic mouse brain
Florence Clavaguera et al.
NATURE CELL BIOLOGY (2009)
Genome-wide association study reveals genetic risk underlying Parkinson's disease
Javier Simon-Sanchez et al.
NATURE GENETICS (2009)
Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease
Dennis W. Dickson et al.
ACTA NEUROPATHOLOGICA (2008)
Neurofibrillary tau pathology modulated by genetic variation of α-synuclein
Terhi Peuralinna et al.
ANNALS OF NEUROLOGY (2008)
Sequence determinants regulating fibrillation of human α-synuclein
Hyun-Jung Koo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Empiric refinement of the pathologic assessment of Lewy-related pathology in the dementia patient
James B. Leverenz et al.
BRAIN PATHOLOGY (2008)
CHIP targets toxic α-synuclein oligomers for degradation
Julie E. Tetzlaff et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Tau exon 10 alternative splicing and tauopathies
Fei Liu et al.
MOLECULAR NEURODEGENERATION (2008)
Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation
Jia-Yi Li et al.
NATURE MEDICINE (2008)
Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease
Jeffrey H. Kordower et al.
NATURE MEDICINE (2008)
Phosphorylation of tau and α-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer's disease, and in Parkinson's disease and related α-synucleinopathies
G. Muntane et al.
NEUROSCIENCE (2008)
Parkinsonism and impaired axonal transport in a mouse model of frontotemporal dementia
Lars M. Ittner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Different species of α-synuclein oligomers induce calcium influx and seeding
Karin M. Danzer et al.
JOURNAL OF NEUROSCIENCE (2007)
Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease
Cyrus P. Zabetian et al.
ANNALS OF NEUROLOGY (2007)
Tau and α-synuclein in susceptibility to, and dementia in, Parkinson's disease
An Goris et al.
ANNALS OF NEUROLOGY (2007)
α-synuclein and its disease-related mutants interact differentially with the microtubule protein tau and associate with the actin cytoskeleton
Alessandro Esposito et al.
NEUROBIOLOGY OF DISEASE (2007)
Proteomic identification of novel proteins in cortical Lewy bodies
James B. Leverenz et al.
BRAIN PATHOLOGY (2007)
Small heat shock proteins protect against α-synuclein-induced toxicity and aggregation
Tiago Fleming Outeiro et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Alpha-Synuclein induces hyperphosphorylation of Tau in the MPTP model of Parkinsonism
Tetyana Duka et al.
FASEB JOURNAL (2006)
Microtubule binding and clustering of human Tau-4R and Tau-P301L proteins isolated from yeast deficient in orthologues of glycogen synthase kinase-3β or cdk5
Tom Vandebroek et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
An inhibitor of tau hyperphosphorylation prevents severe motor impairments in tau transgenic mice
Sylvie Le Corre et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Lewy body pathology in familial Alzheimer disease - Evidence for disease- and mutation-specific pathologic phenotype
JB Leverenz et al.
ARCHIVES OF NEUROLOGY (2006)
Interface between tauopathies and synucleinopathies: A tale of two proteins
WR Galpern et al.
ANNALS OF NEUROLOGY (2006)
Substantia nigra tangles are related to gait impairment in older persons
JA Schneider et al.
ANNALS OF NEUROLOGY (2006)
GSK3B polymorphisms alter transcription and splicing in Parkinson's disease
JBJ Kwok et al.
ANNALS OF NEUROLOGY (2005)
Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration
AM Pittman et al.
JOURNAL OF MEDICAL GENETICS (2005)
The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy
GU Höglinger et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Disruption of the interaction of α-synuclein with microtubules enhances cell surface recruitment of the dopamine transporter
C Wersinger et al.
BIOCHEMISTRY (2005)
Tau gene transfer, but not alpha-synuclein, induces both progressive dopamine neuron degeneration and rotational behavior in the rat
RL Klein et al.
NEUROBIOLOGY OF DISEASE (2005)
A systematic review of prevalence studies of dementia in Parkinson's disease
D Aarsland et al.
MOVEMENT DISORDERS (2005)
Abundant neuritic inclusions and microvacuolar changes in a case of diffuse Lewy body disease with the A53T mutation in the α-synuclein gene
K Yamaguchi et al.
ACTA NEUROPATHOLOGICA (2005)
Interaction between tau and alpha-synuclein proteins is impaired in the presence of P301L tau mutation
L Benussi et al.
EXPERIMENTAL CELL RESEARCH (2005)
Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both
ML Kraybill et al.
NEUROLOGY (2005)
The co-chaperone carboxyl terminus of Hsp70-interacting protein (CHIP) mediates α-synuclein degradation decisions between proteasomal and lysosomal pathways
YG Shin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Cognitive status correlates with neuropathologic stage in Parkinson disease
H Braak et al.
NEUROLOGY (2005)
Tau phosphorylation increases in symptomatic mice overexpressing A30P α-synuclein
M Frasier et al.
EXPERIMENTAL NEUROLOGY (2005)
Characterization of α-synuclein aggregation and synergistic toxicity with protein tau in yeast
P Zabrocki et al.
FEBS JOURNAL (2005)
Interaction of α-synuclein and tau genotypes in Parkinson's disease
CE Mamah et al.
ANNALS OF NEUROLOGY (2005)
Regulation of tau isoform expression and dementia
I D'Souza et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2005)
CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation
L Petrucelli et al.
HUMAN MOLECULAR GENETICS (2004)
α-synuclein A53T substitution associated with Parkinson disease also marks the divergence of Old World and New World primates
BA Hamilton
GENOMICS (2004)
The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia
JJ Zarranz et al.
ANNALS OF NEUROLOGY (2004)
α-synuclein locus duplication as a cause of familial Parkinson's disease
MC Chartier-Harlin et al.
LANCET (2004)
Analysis of α-synuclein-associated proteins by quantitative proteomics
Y Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Geldanamycin induces Hsp70 and prevents α-synuclein aggregation and toxicity in vitro
PJ McLean et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Hsp70 reduces α-synuclein aggregation and toxicity
J Klucken et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Fibrillization of α-synuclein and tau in familial Parkinson's disease caused by the A53T α-synuclein mutation
PT Kotzbauer et al.
EXPERIMENTAL NEUROLOGY (2004)
α-synuclein locus triplication causes Parkinson's disease
AB Singleton et al.
SCIENCE (2003)
Idiopathic Parkinson's disease:: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen
H Braak et al.
JOURNAL OF NEURAL TRANSMISSION (2003)
Initiation and synergistic fibrillization of tau and alpha-synuclein
BI Giasson et al.
SCIENCE (2003)
Variable phenotypic expression and extensive tau pathology in two families with the novel tau mutation L315R
E van Herpen et al.
ANNALS OF NEUROLOGY (2003)
TorsinA and heat shock proteins act as molecular chaperones:: suppression of α-synuclein aggregation
PJ McLean et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Proteasomal degradation of tau protein
DC David et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Concurrence of α-synuclein and tau brain pathology in the Contursi kindred
JE Duda et al.
ACTA NEUROPATHOLOGICA (2002)
Tau and α-synuclein pathology in amygdala of parkinsonism-dementia complex patients of Guam
MS Forman et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Chaperone suppression of α-synuclein toxicity in a Drosophila model for Parkinson's disease
PK Auluck et al.
SCIENCE (2002)
Tubulin seeds α-synuclein fibril formation
MA Alim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
A close association of torsinA and α-synuclein in Lewy bodies -: A fluorescence resonance energy transfer study
N Sharma et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype
H Houlden et al.
NEUROLOGY (2001)
14-3-3ζ is an effector of tau protein phosphorylation
M Hashiguchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein
J Lewis et al.
NATURE GENETICS (2000)
NACP/α-synuclein and tau constitute two distinctive subsets of filaments in the same neuronal inclusions in brains from a family of parkinsonism and dementia with Lewy bodies:: double-immunolabeling fluorescence and electron microscopic studies
K Arima et al.
ACTA NEUROPATHOLOGICA (2000)
Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease
HI Hurtig et al.
NEUROLOGY (2000)
Two brothers with frontotemporal dementia and parkinsonism with an N279K mutation of the tau gene
K Arima et al.
NEUROLOGY (2000)
A Drosophila model of Parkinson's disease
MB Feany et al.
NATURE (2000)
Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system
A Abeliovich et al.
NEURON (2000)
分享论文
